These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1826144)

  • 1. Depo Provera and breast cancer.
    McCowan L; Farquhar C; Roke C; Liddell H; Roberts H; Thakurdas N; Wilson J; Say PJ; McClure F
    N Z Med J; 1991 Jan; 104(904):16-7. PubMed ID: 1826144
    [No Abstract]   [Full Text] [Related]  

  • 2. Medroxyprogesterone (Depo Provera) and breast cancer.
    McCowan L
    N Z Med J; 1990 May; 103(889):225-6. PubMed ID: 2140436
    [No Abstract]   [Full Text] [Related]  

  • 3. Depo-Provera: the jury still out.
    Gold RB
    Fam Plann Perspect; 1983; 15(2):78-81. PubMed ID: 6231191
    [No Abstract]   [Full Text] [Related]  

  • 4. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB; Noonan L; Whitehead A
    Bull World Health Organ; 1985; 63(3):513-9. PubMed ID: 2931206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Depo-Provera.
    Sapire KE
    S Afr Med J; 1992 May; 81(9):444-5. PubMed ID: 1533472
    [No Abstract]   [Full Text] [Related]  

  • 7. Contraceptives and cancer--looking for the evidence.
    Cent Afr J Med; 1992 Feb; 38(2):88-9. PubMed ID: 1387044
    [No Abstract]   [Full Text] [Related]  

  • 8. Depo-Provera--missing the point?
    Fennessy S
    Aust Fam Physician; 1988 Oct; 17(10):839-40. PubMed ID: 2977094
    [No Abstract]   [Full Text] [Related]  

  • 9. Concerns voiced on Depo Provera.
    Sanders C
    RNAO News; 1986; 42(3):15, 22. PubMed ID: 2940668
    [No Abstract]   [Full Text] [Related]  

  • 10. Depo-provera. A lesson in communication.
    Dennerstein G
    Aust Fam Physician; 1988 Mar; 17(3):176-8. PubMed ID: 2965569
    [No Abstract]   [Full Text] [Related]  

  • 11. The Depo-Provera public hearing.
    Dening FC
    Midwives Chron; 1983 Jul; 96(1146):246. PubMed ID: 6225940
    [No Abstract]   [Full Text] [Related]  

  • 12. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depo-Provera--antineoplastic agents which is also a contraceptive].
    Tylleskär J
    Jordemodern; 1988 Mar; 101(3):55-8. PubMed ID: 2967271
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypersensitivity reaction to Depo-Provera.
    Zacest R; Cushway A; Haines C; Cox LW
    Med J Aust; 1982 Jan; 1(1):12. PubMed ID: 6460921
    [No Abstract]   [Full Text] [Related]  

  • 15. DMPA and breast cancer: the dog has had its day.
    Lancet; 1991 Oct; 338(8771):856-7. PubMed ID: 1681220
    [No Abstract]   [Full Text] [Related]  

  • 16. The case for depo provera.
    Cooling H; Christopher E
    Health Visit; 1989 Oct; 62(10):320. PubMed ID: 2530193
    [No Abstract]   [Full Text] [Related]  

  • 17. Depo-Provera. Controversial contraceptive wins approval from FDA panel.
    Stone R
    Science; 1992 Jun; 256(5065):1754. PubMed ID: 1535454
    [No Abstract]   [Full Text] [Related]  

  • 18. Depot medroxyprogesterone and risk of breast cancer.
    Gray RH
    BMJ; 1989 Oct; 299(6707):1099. PubMed ID: 2531619
    [No Abstract]   [Full Text] [Related]  

  • 19. What is breast cancer risk with Depo-Provera?
    Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic papillopathy and contraceptives.
    Li ZH; Fu SJ
    Chin Med J (Engl); 1988 Jun; 101(6):446-7. PubMed ID: 2975585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.